Company
United StatesNovo Nordisk Pharmaceutical Industries LP, Durham, NC – FDA Inspections
Inspection records and compliance data for Novo Nordisk Pharmaceutical Industries LP in Durham, North Carolina. 5 FDA inspections on record, 1 Form 483, last inspected July 30, 2025.
Company Profile
This profile covers Novo Nordisk Pharmaceutical Industries LP based in Durham, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected December 1, 2016. Last inspected July 30, 2025.
Most cited issue areas
- Approve or reject components, products1 inspection
- Equipment for Environmental Control1 inspection
- Establishment of time limitations1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 30, 2025 | Not classified | Human Drugs | 1274952 |
| August 29, 2024 | VAI | Human Drugs · New Drug Evaluation | 1248200 |
| December 20, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1233201 |
| December 20, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1079946 |
| December 1, 2016 | NAI | Human Drugs · Drug Quality Assurance | 1010958 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novo Nordisk Pharmaceutical Industries LP
FEI Number
3016799712
Address
5235 International Dr, Durham, North Carolina 27712, United States
Country
United States
ID: 6bd6ea0d-568a-4f97-ba33-f6bbab29a175